Biotechnology in India: Market Research Report

April 2012 | 396 pages | ID: B80F2757466EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the market for Biotechnology in India in US$ million by the following Key Sectors: Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial, Bioinformatics, and Bio-Services.

Annual estimates and forecasts are provided for the period 2009 through 2017.

Also, a six-year historic analysis is provided for this market.

The report profiles 102 companies including many key and niche players such as Advanced Enzymes Technologies Ltd., Ajeet Seeds Ltd., Anthem BioSciences Pvt.Ltd., Bharat Biotech International Limited, Bharat Serums and Vaccines Ltd., Biocon Limited, Syngene International Limited, Dr. Reddy's Laboratories Ltd., Ecron Acunova, Eli Lilly and Company (India) Pvt.Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Indian Immunologicals Ltd., Jubilant Life Sciences Limited, Krishidhan Seeds Private Limited, Lambda Therapeutic Research Ltd., Mahyco, Max Neeman, Monsanto, Novo Nordisk India Pvt.Ltd., Novozymes South Asia Pvt.Ltd., Nuziveedu Seeds Pvt.Ltd., Ocimum Biosolutions Ltd., Panacea Biotec Ltd., Piramal Healthcare Limited, Quintiles India, Rasi Seeds (P) Ltd., Reliance Life Sciences, Serum Institute of India Ltd., Shantha Biotechnics Limited, SIRO Clinpharm, Strand Life Sciences, Veeda Clinical Research Limited, and Vimta Labs Limited.

Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based upon search engine sources in the public domain.

Contents

I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definition and Scope of Study
Bio-Pharmaceuticals
Bio-Agriculture
Bio-Industrial
Bioinformatics
Bio-Services

II. AN INDIAN MARKET REPORT

1.OUTLOOK

Recession and Foreign Exchange Rate Decelerate Industry Growth
Industry Emerges Strong Following Recession
Brighter Prospects Ahead for the Indian Biotech Industry

2.INDUSTRY OVERVIEW

SWOT Analysis
Diversity – Key Strength for the Industry
Major Sectors in the Indian Biotechnology Industry
Government Support for Biotech Innovation – A Boost for the Industry
Challenges Ahead
Concerted Efforts are On to Find a Way Out
Major Industry-Specific Advantages of the Indian Biopharma Sector
Competition

Table 1. Leading Biotech Companies in India by Revenues: 2009-10 (includes corresponding Graph/Chart)

Table 2. Leading Domestic Biotech Companies in India by Revenues: 2009-10 (includes corresponding Graph/Chart)

Exports – A Major Market for Indian Biotech Industry

Table 3. Export Revenues of Indian Biotech Industry by Sector (2008-09 & 2009-10): Export Value in US$ Million for Bio-Pharma, Bio-Services, Bio-Agri, Bio-Industrial, and Bioinformatics (includes corresponding Graph/Chart)

Table 4. Biotechnology Industry Export Revenues as a Percentage Share of Total Segment Revenues: 2009-10 (includes corresponding Graph/Chart)

Analysis by Region
Western Region’s Domination Continues in Revenue Terms, Mumbai Moves to the Top

Table 5. Leading States in the Indian Biotech Industry by Revenues: 2009-10 (includes corresponding Graph/Chart)

Table 6. Leading Cities In the Indian Biotech Industry by Revenues: 2009-10 (includes corresponding Graph/Chart)

Karnataka Embarks on Further Growth Plans; Other Regions Join the League

3.ISSUES AND TRENDS

Government Support to the Biotechnology Sector Surges
Recognizing the Importance of Right Educational System
Need for a Streamlined Regulatory Process Continues
Angel Funding – Still Eluding the Sector
More Countries Look to India for Outsourcing
China and India – Competing for Biotech Investments

4.BIO-PHARMACEUTICALS IN INDIA

Table 7. Indian Bio-Pharmaceuticals Market by Segment (2011): Percentage Share Breakdown for Vaccines, Diagnostics, Therapeutics, and Others (includes corresponding Graph/Chart)

Competitive Landscape of the Biopharma Sector

Table 8. Leading BioPharma Companies in India by Revenues: 2009-10 (includes corresponding Graph/Chart)

Market Analysis by Segment
Vaccines
Vaccines to Spearhead Growth in the Indian BioPharma Market
Demand for Vaccines to Surge
India to Emerge as a Global Hub for Vaccines
Diagnostics
India Diagnostics Market – An Overview

Table 9. Leading Players in the Indian Diagnostics Market by Revenues: Market Share Breakdown of Revenues for Tulip, TransAsia Biomedical, Bayer, Span Diagnostics, and Others (2010) (includes corresponding Graph/Chart)

Indian Diagnostics Industry – Stifled with High Competition
Diagnostic Centers Expand Test Menu to Beat Competition
Bio-Therapeutics - Going Strong
Overseas Giants Dominate the Insulin Market
Plasma Proteins – A Potential Growth Area
mAbs Gain Prominence in the Biopharma Industry
Market Trends
Climbing Up the Value Chain
Domestic Market to Provide Impetus to Bio-Pharma Industry Growth
Biosimilars to Offer Tremendous Prospects for Indian Players

Table 10. Indian Market for Biosimilars by Drug Class (2009): Revenues for Insulin, EPO, Interferon, Streptokinase, and G-CSF (includes corresponding Graph/Chart)

Biopharmaceutical Pipeline Growth Continues
r-DNA Biopharmaceuticals Cleared for Pre-Clinical Studies: 2009-10
Indian Firms Embrace Strategic Partnerships to Enter Biotech Industry
Indian Biopharma Market Luring Overseas Players
Indian Pharma Companies on a Co-Development Spree
Vaccines Remain the Center of Focus in Indian BioPharma
Brighter Prospects Ahead in Original Drug Development
Myriad Factors Drive Growth in the Indian BioPharma Sector
Pharma Companies Shift Focus to BioPharma

5.BIO-AGRICULTURE IN INDIA

Indian Bio-Agriculture Industry – An Overview
Select Biotech Crops in India Under Field Trials: 2008
Transgenic Crops Cleared for Limited Field Trials: 2009-10
India – A Leading Adopter of Biotech Crops Worldwide
Bio-Agri Treads On A Fast-Track Growth Path
Public and Private Sector Participation in Bio-Agri Research
Bt Cotton – A Major Success in India
Indian Farmers Increasingly Embrace Bollgard II Cotton
Monsanto And Mahyco to Battle Out Pink Bollworm Resistance in Bollgard – I
Move to Commercialize Bt Brinjal Draws Major Controversy
Government Retreats, Imposes Moratorium on Launch of Bt Brinjal
Moratorium on Bt Brinjal Launch, A Setback to the Industry?
Establishment of BRAI Also Faces the Heat of Opponents
Stark Criticism Compels India to Establish Transparent Administration of Biotech Procedures
Bio-Diesel Market – Still in Infancy
Bio-Fertilizers and Bio-Pesticides Market – An Overview
Competitive Scenario in the Bio-Agri Sector

Table 11. Leading Bio-Agriculture Companies in India by Revenues: 2009-10 (includes corresponding Graph/Chart)

6.BIO-INDUSTRIAL SECTOR IN INDIA

Indian Bio-Industrial Sector – Fairly Concentrated

Table 12. Leading Players in the Indian Bio-Industrial Sector (2009-10): Market Share as Percentage of Revenues for Novozymes, Advanced Enzyme Technologies, and Others (includes corresponding Graph/Chart)

7.BIOINFORMATICS

Indian BioInformatics Market Posts Sluggish Growth

8.BIO-SERVICES

Indian Bio-Services Market Bustling with Activity
India – A Growing Hub for Clinical Trials
Competitive Scenario

Table 13. Leading Biotechnology Services Companies in India By Revenues (2009-10) (includes corresponding Graph/Chart)

9.REGULATORY SETUP

Regulatory Evolution in the Country
Department of Biotechnology
Public Sector Undertakings under the DBT
Autonomous Institutions operating under the DBT
Roles and Responsibilities of DBT
Various Committees Operating Under the DBT and MoEF
GEAC or the Genetic Engineering Approval Committee
Review Committee on Genetic Manipulation
Institutional Bio-Safety Committee
Recombinant DNA Advisory Committee
Central Drugs Standard Control Organization
Select Acts, guidelines and regulations that govern the biotechnology industry in India
Agencies Supporting and Financing Biotechnology Research in India
New Regulatory Framework on the Horizon
National Biotechnology Strategy

10.INDUSTRY INFRASTRUCTURE

Biotech and Science Parks in the Country
Select Biotech and Science Parks in India
Major Research Institutes in India
Select Key Research Institutes in India
Autonomous Biotechnology Institutes in India

11.BIOTECHNOLOGY – AN OVERVIEW

Biotechnology
A Peek into the History of Biotechnology
Select Major Applications of Biotechnology
Medicine
Pharmacogenomics
Biopharmaceuticals
Genetic Testing
Gene Therapy
Cloning
Agriculture
Bioremediation and Biodegradation

12.PRODUCT APPROVALS/LAUNCHES

Panacea Biotec to Introduce PacliALL
Gene Logic Rolls Out ASCENTA System Version 4.0
Bharat Biotech International Unveils HNVAC™ H1N1 Swine Flu Vaccine
Strand Scientific Intelligence Introduces Avadis NGS
Dr Reddy’s Rolls Out Generic Darbepoetin Alfa Drug, Cresp®
BD Biosciences and ReaMetrix Unveil New Reagents
Serum Institute of India Rolls Out Nasovac H1N1 Vacccine in India
Ocimum Biosolutions Introduces Biotracker™
Novo Nordisk Launches Antidiabetic Drug, Victoza in India
Cadila Healthcare Launches Vaxiflu-S
Ocimum Biosolutions Introduces qRT-PCR Services
Wockhardt Rolls Out Biotechnology Products
Intas Biopharma Launches Borviz in India
Bharat Biotech International Unveils COMVAC5® Vaccine

13.RECENT INDUSTRY ACTIVITY

Piramal Healthcare to Change Name to Piramal Enterprises
Bharat Biotech Commences Phase III Clinical Trial with THR-100
Bayer Teams Up with Zydus for Joint Venture in India
Qiagen Establishes Qiagen India
Ecron Acunova Expands Capacity at Mangalore Clinical Research Center
IndianOil Inks MOU with LanzaTech
Dow AgroSciences and GVK Biosciences Discover New Compound
Ecron Acunova Establishes Joint Venture CRO in Thailand
Praj Industries Enters into Partnership with Qteros
Mavens Biotech to Venture into Biotech Education
Aurobindo Pharma to Divest Stake in Its Chinese Subsidiary
Abbott Acquires Formulation Business of Piramal Healthcare
Evolvence India Life Sciences Takes Over Stake in Fermenta Biotech
Strides Arcolab to Take Over 70% Stake in Inbiopro Solutions
Rallis Acquires Majority Stake in Metahelix
Ocimum Secures US$8 Million Funding for Future Growth
Dr. Reddy's to Purchase US Penicillin Facility and Product Rights from GSK
Life Technologies to Take Over Labindia
Biocon Enters into Strategic Global Agreement with Pfizer
Intas Biopharma to Ink Out-Licensing Deal with Japanese Firm
Biocon Limited and CMI Enter into Immunology Research Collaboration
Biocon Signs Contract with Teleradiology Solutions
Jubilant Organosys Changes Name to Jubilant Life Sciences
Jubilant Inks CRAMS Deal with a US Firm
MSCCC and Strand Life Sciences Ink MOU for Translational Cancer Research
Lohmann Animal Health Enters into Joint Venture with Suguna
International Stem Cell Inks a Distribution Agreement with Sristi Biosciences
BioServe Biotechnologies Receives NABL Accreditation for GMO Testing
Indian Immunologicals to Develop Oral Cervical Cancer Vaccine
Piramal Healthcare to Take Over the Assets of BioSyntech
Ocimum Biosolutions to Offer BioIT Consulting Services
Zydus Obtains DCGI Clearance for Initiating Phase I Trials on Zyog1
Krishidhan Establishes Subsidiary in Europe
Biocon Limited Inks Supply Deal with Optimer Pharmaceuticals
Australia to Grant Research Funding to India
Ocimum Biosolutions and Jivan Biologics Enter into Partnership
Stempeutics Completes Phase I/II Study of Stemepucel-CLI Stem Cell Product
Ranbaxy Enters into Alliance with Pfenex
Syngene Collaborates with Endo Pharmaceuticals
Panacea Biotech Obtains Financial Assistance from DBT for Vaccine Development
M. D. Anderson Cancer Center Selects Biotracker™ of Ocimum Biosolutions
GVK Biosciences Establishes New Clinical Pharmacology Unit
Delta Embedded Solutions to merge with Bio-Analytical Technologies
Clingene Seeks Alliance with SIRO Clinpharm
Biocon Investments in Malaysian Biotech Market
Ranbaxy to Foray into Vaccines Market through Acquisition of Biovel's Assets
Clinigene International Deploys PheedIt Solution of SAS
Sanofi Takes Over Shantha Biotech
Bioseed Research India Inks Strategic Partnership Agreement with KeyGene
PRAJ Partners with Novozymes
Mylan sells stake in Concord Biotech
Vibha Seeds Sets Up Seed Facility in Andhra Pradesh
Bayer Cropscience Inks Research Cooperation Agreement with GVK Biosciences
Millipore Acquires Outstanding Stake of its Joint Venture in India
Avesthagen Forms Joint Venture with Limagrain
Indus Biotech Receives HIV Controller Status for IND02 from FDA
Bharat Biotech Commences Construction at Konark Knowledge Park in Orissa
International Biotech Park to Forge International Alliances
Merck Acquires Bangalore Genei
Bharat Biotech Secures International Patents for Lysostaphin
Genzyme Inks MoU with NIPER for Offering Biotechnology Fellowships
Biocon Enters into Agreement with Amylin Pharmaceuticals
WHO and DCGI Direct Serum Institute of India to Focus on H1N1 Vaccine
Acoris Research Enters into Strategic Partnership with c-LEcta
Serum Institute of India to Expedite Vaccine Development
Sanofi Aventis Acquires Shantha Biotechnics
Biocon Inks a Strategic Collaboration Agreement with Mylan
Lonza to Invest in Genome Valley for Two Major Projects
Bio-Rad Laboratories Integrates DiaMed Scientific Technologies in India
Syngene Enters into Alliance with DuPont Crop Protection
Emami Biotech Limited and Calcutta Tramways Company Ink MoU
TCG Lifesciences and Pfizer Extend Master Services Agreement
Biological E Commences Operations at New Campus
Syngene Enters into Partnership with Sapient
Intas Biopharmaceuticals Inks MoU with Government of Gujarat
Emami’s Bio-Diesel Obtains SGS Certification
Ocimum Biosolutions Enters into Partnership with NuGEN

14.STRATEGIC CORPORATE DEVELOPMENTS – A HISTORIC PERSPECTIVE BUILDER

Biocon Collaborates with Abraxis to Introduce Abraxane in India
Intas Biopharmaceuticals Takes Over BPD
Bharat Biotech Completes Phase I/II Clinical Trials for 116E Oral Rotavirus Vaccine
Intas Biopharmaceuticals to Commercialize Gefitinib in India
Avesthagen Inks LoI with ShigaMediX
Ranbaxy Signs Collaborative Research Agreement with DBT
Veeda Establishes Global Oncology Contract Research Organization
Avesthagen Signs Framework Agreement with DuBiotech
Biocon Buys Majority Stake in German Company
Monsanto India to Sell Butachlor & Alachlor Businesses to Sinochem International
Biocon Signs Strategic Partnership Agreement with IATRICa
Intas Pharmaceuticals to Sell Biotechnology Products in GCC

15.FOCUS ON SELECT LEADING PLAYERS

Advanced Enzymes Technologies Ltd.
Ajeet Seeds Ltd.
Anthem BioSciences Pvt. Ltd.
Bharat Biotech International Limited
Bharat Serums and Vaccines Ltd.
Biocon Limited
Syngene International Limited
Dr. Reddy's Laboratories Ltd
Ecron Acunova
Eli Lilly and Company (India) Pvt. Ltd.
GlaxoSmithKline Pharmaceuticals Ltd.
Indian Immunologicals Ltd.
Jubilant Life Sciences Limited
Krishidhan Seeds Private Limited
Lambda Therapeutic Research Ltd.
Mahyco
Max Neeman
Monsanto
Novo Nordisk India Pvt. Ltd.
Novozymes South Asia Pvt. Ltd.
Nuziveedu Seeds Pvt. Ltd.
Ocimum Biosolutions Ltd.
Panacea Biotec Ltd.
Piramal Healthcare Limited
Quintiles India
Rasi Seeds (P) Ltd.
Reliance Life Sciences
Serum Institute of India Ltd.
Shantha Biotechnics Limited
SIRO Clinpharm
Strand Life Sciences
Veeda Clinical Research Limited
Vimta Labs Limited

16.MARKET ANALYTICS

Table 14. Indian Recent Past, Current & Future Analysis for Biotechnology Industry by Sector – Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial, Bioinformatics, and Bio-Services Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 15. Indian Historic Review for Biotechnology Industry by Sector– Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial, Bioinformatics, and Bio-Services Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

Table 16. Indian 15-Year Perspective for Biotechnology Industry by Sector – Percentage Breakdown of Dollar Sales for Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial, Bioinformatics, and Bio-Services Markets for Years 2003, 2011 and 2017 (includes corresponding Graph/Chart)

Table 17. Indian Recent Past, Current & Future Analysis for Bio-Pharmaceuticals by Segment – Vaccines, Diagnostics, Therapeutics, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)

Table 18. Indian Historic Review for Bio-Pharmaceuticals by Segment – Vaccines, Diagnostics, Therapeutics, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)

Table 19. Indian 15-Year Perspective for Bio-Pharmaceuticals by Segment – Percentage Breakdown of Dollar Sales for Vaccines, Diagnostics, Therapeutics, and Others Markets for Years 2003, 2011 and 2017 (includes corresponding Graph/Chart)

III. COMPETITIVE LANDSCAPE

Total Companies Profiled: 102 (including Divisions/Subsidiaries - 111)
India (111)